Celecoxib
- Product NDC
- 51079-215
- 11-digit product format
- 510790215
- Labeler code
- 51079
- Product ID
- 51079-215_d3d6bc60-ea52-5f29-e053-2a95a90a8abd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- celecoxib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Mylan Institutional Inc.
- Application
- ANDA078857
- Marketing category
- ANDA
- Marketing start
- 2015-02-24
- Marketing end
- 2022-11-30
- Substance
- CELECOXIB
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51079-215-20 | 51079021520 | 100 BLISTER PACK in 1 CARTON (51079-215-20) > 1 CAPSULE in 1 BLISTER PACK (51079-215-01) | 100 blister pack | 2015-02-24 | 0000-00-00 | No | No | Current |